The global next generation sequencing market is set to witness a growth rate of ~15% in the next 5 years. Rising demand for ...
The global next-generation sequencing informatics market value was US$ 1057.2 million in 2021. The global next-generation sequencing informatics market value is forecast to reach US$ 3252.8 million by ...
Enzymes are important tools, and a new technology combining microbiology and AI has exciting potential to advance their use in many applications ...
Zacks Investment Research on MSN
Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD
RNA sequencing provides a comprehensive view of biological information, offering deeper insights into disease mechanisms, including improved fusion detection. As a powerful tool in research and ...
The T7+ integrates MGI's proprietary DNBSEQ™ technology with next-generation fluidics, optics, and bioinformatics, creating a ...
Tempus said that the RNA-based xR IVD assay will be offered as a life sciences tool to support drug development programs.
OGT will now offer Qiagen's Clinical Insight Interpret bioinformatics software along with its SureSeq next-generation sequencing panels.
Life sciences company Element Biosciences sued Illumina on Monday in separate cases in federal courts in California and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback